Literature DB >> 11773404

Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.

Juliet V Spencer1, Kristen M Lockridge, Peter A Barry, Gaofeng Lin, Monica Tsang, Mark E T Penfold, Thomas J Schall.   

Abstract

Cytomegalovirus (CMV) has highly evolved mechanisms for avoiding detection by the host immune system. Recently, in the genomes of human and primate CMV, a novel gene comprising segments of noncontiguous open reading frames was identified and found to have limited predicted homology to endogenous cellular interleukin-10 (IL-10). Here we investigate the biological activities of the CMV IL-10-like gene product and show it to possess potent immunosuppressive properties. Both purified bacterium-derived recombinant CMV IL-10 and CMV IL-10 expressed in supernatants of human cells were found to inhibit proliferation of mitogen-stimulated peripheral blood mononuclear cells (PBMCs), with specific activity comparable to that of recombinant human IL-10. In addition, CMV IL-10 expressed from human cells inhibited cytokine synthesis, as treatment of stimulated PBMCs and monocytes with CMV IL-10 led to a marked decrease in production of proinflammatory cytokines. Finally, CMV IL-10 was observed to decrease cell surface expression of both major histocompatibility complex (MHC) class I and class II molecules, while conversely increasing expression of the nonclassical MHC allele HLA-G. These results demonstrate for the first time that CMV has a biologically active IL-10 homolog that may contribute to immune evasion during virus infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773404      PMCID: PMC135865          DOI: 10.1128/jvi.76.3.1285-1292.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Primate cytomegaloviruses encode and express an IL-10-like protein.

Authors:  K M Lockridge; S S Zhou; R H Kravitz; J L Johnson; E T Sawai; E L Blewett; P A Barry
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

Review 2.  Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist.

Authors:  H Hengel; W Brune; U H Koszinowski
Journal:  Trends Microbiol       Date:  1998-05       Impact factor: 17.079

Review 3.  Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression.

Authors:  M B McChesney; M B Oldstone
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

4.  Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10.

Authors:  S Redpath; A Angulo; N R Gascoigne; P Ghazal
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

Review 5.  Interleukin-10 gene knock-out mice: a model of chronic inflammation.

Authors:  D Rennick; N Davidson; D Berg
Journal:  Clin Immunol Immunopathol       Date:  1995-09

Review 6.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes.

Authors:  R P Donnelly; H Dickensheets; D S Finbloom
Journal:  J Interferon Cytokine Res       Date:  1999-06       Impact factor: 2.607

7.  Identification of functional domains on human interleukin 10.

Authors:  B Gesser; H Leffers; T Jinquan; C Vestergaard; N Kirstein; S Sindet-Pedersen; S L Jensen; K Thestrup-Pedersen; C G Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients.

Authors:  I Nordøy; F Müller; K P Nordal; H Rollag; E Lien; P Aukrust; S S Froland
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

9.  The genome of equine herpesvirus type 2 harbors an interleukin 10 (IL10)-like gene.

Authors:  H J Rode; W Janssen; A Rösen-Wolff; J J Bugert; P Thein; Y Becker; G Darai
Journal:  Virus Genes       Date:  1993-02       Impact factor: 2.332

10.  Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.

Authors:  D M Miller; B M Rahill; J M Boss; M D Lairmore; J E Durbin; J W Waldman; D D Sedmak
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

View more
  121 in total

1.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

3.  Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.

Authors:  Noelle D Brodeur; Juliet V Spencer
Journal:  Virus Res       Date:  2010-08-20       Impact factor: 3.303

4.  Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?

Authors:  Fathiah S Amran; Kyungchul Kim; Andrew Lim; Rachel Thomson; Silvia Lee; Grant Waterer; Patricia Price
Journal:  J Clin Immunol       Date:  2016-01-13       Impact factor: 8.317

5.  Viral binding-induced signaling drives a unique and extended intracellular trafficking pattern during infection of primary monocytes.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Patrizia Caposio; Andrew D Yurochko
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

Review 6.  Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Authors:  Emmanuel J Wiertz; Robert Devlin; Helen L Collins; Maaike E Ressing
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

8.  Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions.

Authors:  Sara Gredmark; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

10.  The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4.

Authors:  Kathleen L Arnolds; Angela P Lares; Juliet V Spencer
Journal:  Virology       Date:  2013-03-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.